Eiko Lifesciences Rights Issue will open for subscription from 17 July 2023. the company aims for an issue size of ₹24.95 Crores through this rights Issue.
About the company
Incorporated in 1977, Eiko LifeSciences Limited is engaged in the manufacturing, supplying, and export business of Speciality Chemicals and Pharma Intermediates. The company supplies its offerings in India and worldwide. The products of the company are used in segments like Pharmaceuticals, Agrochemicals, Aroma Chemicals, Electronic Chemicals, and others. Eiko LifeSciences established a manufacturing unit at MIDC, Badlapur, and has also tied up with many job-workers for manufacturing.
Objectives of the Issue
- Funding incremental working capital requirements of our Company.
- To meet General corporate purposes.
- To meet the expenses of the Issue.
Rights Issue Timetable
| Last Date to buy shares | 06 July 2023 |
| Record Date | 07 July 2023 |
| Credit of Rights Entitlements | 12 July 2023 |
| Bid/Offer Opens On | 17 July 2023 |
| Renunciation of Rights Entitlements | 20 July 2023 |
| Bid/Offer Closes On | 26 July 2023 |
| Deemed Date of Allotment | 03 August 2023 |
| Credit Date | 04 August 2023 |
| Listing Date | 10 August 2023 |
Eiko Lifesciences Rights Issue Details
| Issue Open | Jul 17, 2023 – Jul 26, 2023 |
| Security Name | Eiko Lifesciences Limited |
| Issue Size (Shares) | 5,544,178 |
| Issue Size (Amount) | ₹24.95 Crores |
| Issue Price | ₹45 per share |
| Face Value | ₹10 per share |
| Listing At | BSE |
| Terms of Payment | The amount of Rs. 13.50 per Rights Equity Share (including premium of Rs. 10.50) is to be paid on the Application. Balance to be paid in not more than two calls as determined by the Board. |
| Entitlement | 2 Rights Equity Share(s) for every 3 fully paid-up Equity Shares held on Record Date |
Company Financials
| Period Ended | Total Assets | Total Revenue | Profit After Tax |
|---|---|---|---|
| 31-Mar-21 | 16.61 | 12.45 | 0.61 |
| 31-Mar-22 | 34.89 | 26.09 | 0.71 |
Rights Issue Documents
Lead Manager(s)
- Pnb Investment Services Ltd
Rights Issue Registrar
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: rightsissue@bigshareonline.com
Website: https://ipo.bigshareonline.com/ipo_status.html
Company Contact Information
Eiko Lifesciences Limited
604, Centrum, Opp. TMC Office,
Near Satkar Grande Hotel, Wagle Estate,
Thane – 400604
Phone: 022-2539 0009
Email: investor.relations@eikolifesciences.com
Website: https://www.eikolifesciences.com/
Final Thoughts
Applying for the rights issue is purely a personal choice. make sure you make a detailed study about the company and rights issue before you make an investment decision.
Happy investing
